These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3469057)

  • 1. The serotonin uptake inhibitor citalopram attenuates ethanol intake.
    Naranjo CA; Sellers EM; Sullivan JT; Woodley DV; Kadlec K; Sykora K
    Clin Pharmacol Ther; 1987 Mar; 41(3):266-74. PubMed ID: 3469057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers.
    Sellers EM; Naranjo CA; Kadlec K
    J Clin Psychopharmacol; 1987 Dec; 7(6):417-20. PubMed ID: 2963034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of viqualine on alcohol intake and other consummatory behaviors.
    Naranjo CA; Sullivan JT; Kadlec KE; Woodley-Remus DV; Kennedy G; Sellers EM
    Clin Pharmacol Ther; 1989 Sep; 46(3):301-9. PubMed ID: 2673621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers.
    Naranjo CA; Sellers EM
    Recent Dev Alcohol; 1989; 7():255-66. PubMed ID: 2522667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
    Naranjo CA; Poulos CX; Bremner KE; Lanctôt KL
    Clin Pharmacol Ther; 1992 Jun; 51(6):729-39. PubMed ID: 1535302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations in the measurement of urine ethanol in clinical trials to monitor ethanol consumption.
    Sellers EM; Kadlec KE; Kaplan HL; Naranjo CA
    J Stud Alcohol; 1988 Nov; 49(6):567-70. PubMed ID: 2976866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance among heavy alcohol users in clinical drug trials.
    Sullivan JT; Naranjo CA; Sellers EM
    J Subst Abuse; 1988-1989; 1(2):183-94. PubMed ID: 2980999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers.
    Naranjo CA; Sellers EM; Roach CA; Woodley DV; Sanchez-Craig M; Sykora K
    Clin Pharmacol Ther; 1984 Mar; 35(3):374-81. PubMed ID: 6230195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serotonin uptake blockers and of 5-hydroxytryptophan on the voluntary consumption of ethanol, water and solid food by UChA and UChB rats.
    Alvarado R; Contreras S; Segovia-Riquelme N; Mardones J
    Alcohol; 1990; 7(4):315-9. PubMed ID: 2143905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin uptake blockers and the treatment of alcoholism.
    Gorelick DA
    Recent Dev Alcohol; 1989; 7():267-81. PubMed ID: 2648494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine attenuates alcohol intake and desire to drink.
    Naranjo CA; Poulos CX; Bremner KE; Lanctot KL
    Int Clin Psychopharmacol; 1994 Sep; 9(3):163-72. PubMed ID: 7814825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.
    Bjerkenstedt L; Flyckt L; Overø KF; Lingjaerde O
    Eur J Clin Pharmacol; 1985; 28(5):553-7. PubMed ID: 3899675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivation after single-doses of the new antidepressants femoxetine, mianserin and citalopram. A cross-over study.
    Clemmesen L; Jensen E; Min SK; Bolwig TG; Rafaelsen OJ
    Pharmacopsychiatry; 1984 Jul; 17(4):126-32. PubMed ID: 6591216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of serotonergic drugs in alcohol abuse.
    Sellers EM; Naranjo CA
    Clin Neuropharmacol; 1986; 9 Suppl 4():60-2. PubMed ID: 2952271
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.
    Naranjo CA; Kadlec KE; Sanhueza P; Woodley-Remus D; Sellers EM
    Clin Pharmacol Ther; 1990 Apr; 47(4):490-8. PubMed ID: 2328557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies.
    Gill K; Amit Z
    Recent Dev Alcohol; 1989; 7():225-48. PubMed ID: 2648493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a specific 5HT uptake inhibitor (citalopram) on drug accumulation by rat lung slices.
    Drew R; Siddik ZH
    Pharmacology; 1980; 20(1):27-31. PubMed ID: 6929555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.